Timing of Umbilical Cord Clamping in Term Cesarean Deliveries

Status Completed

Clinical Trial Summary

The aim of this study is to show that delayed umbilical cord clamping or milking of the umbilical cord in pregnant women undergoing elective cesarean delivery might have better effects than early clamping, on neonatal results without causing maternal hemorrhage or negatively affecting the neonatal outcome , and to compare the superiority of these three methods to each other.

Clinical Trial Description

Late clamping of the umbilical cord has been shown to have positive effects such as higher neonatal hemoglobin level, higher iron stores in the newborn around three to six months, and better neurological development. In 2017, American College of Obstetricians and Gynecologists (ACOG) recommended a minimum 30-60 seconds delayed clamping of the cord after a minimum of 30-60 seconds, regardless of the delivery method, in both term and preterm newborns. In addition, optimal placental transfusion can be achieved due to strong uterine tonus in vaginal delivery. However, this is not possible due to decreased uterine tonus and time constraint in cesarean delivery. The main concern in delayed clamping and milking of the umbilical cord is the possibility of maternal anemia due to excessive maternal blood loss in the short term, the need for maternal blood transfusion or maternal intensive care support, and the possibility of conditions such as hyperbilirubinemia, symptomatic polycythemia, and long hospital stay that may cause the need for phototherapy in the newborn. Although there are many studies in the literature regarding the neonatal results of the clamping timing of the umbilical cord, there are a limited number of articles regarding the results in patients who underwent term elective cesarean section. The aim of this study is to show that delayed umbilical cord clamping or milking of the umbilical cord in pregnant women undergoing elective cesarean delivery might have better effects than early clamping, on neonatal results without causing maternal hemorrhage or negatively affecting the neonatal outcome , and to compare the superiority of these three methods to each other. ;

Study Design

Related Conditions & MeSH terms

Cesarean Delivery
Delayed Separation of Umbilical Cord

Clinical Trial Details

NCT number	NCT04812223
Study type	Interventional
Source	Acibadem University
Contact
Status	Completed
Phase	N/A
Start date	March 25, 2021
Completion date	July 29, 2021

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03236324` - Transversalis Fascia Plane Blocks for Analgesia Post-cesarean Delivery	Phase 2
Recruiting	`NCT04058444` - The First ERAS Protocol for Cesarean Delivery in Serbia at the University Hospital	N/A
Completed	`NCT03150641` - Delayed Cord Clamping at Term Cesarean	N/A
Recruiting	`NCT06247852` - Persistent Pain After Cesarean Delivery - A Danish Multicenter Cohort Study
Completed	`NCT02846129` - Incidence of Complications Associated With Anesthesia in Multiple Gestation Undergoing Cesarean Delivery	N/A
Completed	`NCT00799955` - Comparing 2 Types of Pain Relief After Cesarean Delivery: Spinal Morphine and TAP Block	N/A
Completed	`NCT03336541` - Low-dose Ketamine and Postpartum Depression in Parturients With Prenatal Depression	Phase 4
Completed	`NCT04358757` - Immune and Physical Recovery Following Cesarean Delivery
Completed	`NCT01755026` - Serum and Tissue Cefazolin Concentrations in Patients Undergoing Cesarean Delivery	Phase 4
Recruiting	`NCT03746678` - Patient-Centred Perioperative Mobile Application
Completed	`NCT03349151` - Postoperative Results of Early Versus On-demand Maternal Feeding After Cesarean Delivery	N/A
Completed	`NCT03729076` - Crystalloid Versus Colloid Rapid Co-load for Cesarean Delivery Under Spinal Anesthesia	N/A
Completed	`NCT04799587` - Accupressure of P6 to Reduce Nausea During Cesarean Section	N/A
Not yet recruiting	`NCT05758012` - Carbetocin Compared To Oxytocin During Cesarean Delivery
Completed	`NCT03781388` - ED90 for Hyperbaric Bupivacaine in Super Obese Parturients	Phase 4
Completed	`NCT04349215` - Validation of the Chinese ObsQoR-11
Recruiting	`NCT05279703` - Epinephrine Infusion for Prophylaxis Against Maternal Hypotension During Cesarean Delivery	Phase 4
Completed	`NCT01550640` - Pharmacogenetics of Remifentanil in Patients With Hypertension Undergoing Cesarean Delivery Under General Anesthesia	N/A
Completed	`NCT00884026` - Can Augmentation Index (AIx) be Used to Predict Hypotension After Spinal Anesthesia?	N/A
Completed	`NCT03830307` - NSS-Bridge Device for Post-Cesarean Delivery Pain	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.